XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating Expenses:    
Research and development $ 970,815 $ 703,783
General and administration expenses 903,397 434,457
Total Operating Expenses 1,874,212 1,138,240
Loss From Operations (1,874,212) (1,138,240)
Other Income (Expenses):    
Interest income 55 16,042
Net Loss $ (1,874,157) $ (1,122,198)
Net Loss Per Share:    
Basic and Diluted $ (0.10) $ (0.06)
Weighted average number of shares used in computing basic and diluted net loss per share:    
Basic and Diluted 18,334,482 17,847,740